The main conclusion reached through the FS is that the project to further develop HEALTH-IN-A-CONT to reach commercialization stage should continue as there is clearly a high market demand for the product and little signs of mature market competition up to the present day. Furthermore, the strategic business plan has been reinforced through the positive response from potential customers and relevant stakeholders (regional and national health services, NGOs, governments) and interest to participate in the envisaged HEALTH-IN-CONT EIC Accelerator project.
TECHNICAL FEASIBILITY: we have studied and identified the main technical developments we need to focus on to adjust our prototype design and get to an optimized version ready for piloting and mass production. Our priorities are: i) increasing the container’s external resistance to limit the impact of a potential deflagration on internal medical equipment; ii) controlling and reducing vibrations within the container to make it adapt to include ophthalmology and other precision techniques; iii) modifying and synchronizing the existing ventilation system. We have identified the different containers we are willing to bring onto market (Operating Room; PCR Laboratory for Testing and Analysis; Intensive Care Unit (ICU); Image Diagnosis Laboratory; Service Container), and also additional solutions we will be able to develop on the basis of our 3D models along with the analysis of the customers’ preferences. We have drafted a first protocol for the standardization of the production process. Taking into account our company’s ongoing negotiations with public health institutions in Spain and international NGOs operating in rural and remote areas, we have decided to select them as first pilot partners. (WP3). Finally, we have analyzed our upstream supply chain to help us create a redundancy system and reduce uncertainty.
COMMERCIAL FEASIBILITY: After analyzing the market in the field of emergency and temporary medical services, and the competitor environment, we have concluded that our ability to deliver different container configurations (Set-ups) will enable us to offer a set of fast development mobile hospitals and responses to any pandemic risk area and that can be moved trough large rural areas with lack of necessary facilities. We have also conducted an in-depth analysis of stakeholders which will be key for HEALTH-IN-A-CONT manufacturing, optimization, promotion and market uptake, and in the implementation of the EIC Accelerator project. We have identified and analyzed the first customer groups which can be directly interested in acquiring our solution. The outlined go-to-market strategy targets initial direct opportunities built up from our existing network, building upon the relations we have built with several organizations and institutions providing health services in emergency situations and remote areas. We have designed a Dissemination Strategy to enhance our company’s visibility and its leadership in the mobile field hospital industry. We have conducted a prior patent search, and have not found any existing product limiting our company’s Freedom-to-Operate. We have clearly identified the relevant regulations and international standards to be followed in the design and manufacturing process. We have outlined our business model, composed of 3 business lines: 1) developing and delivering “on demand” containers (set of containers); 2) developing OEM containers to be set up by the customers themselves. 3) R&D Engineering by licensing our innovation to bigger players which will sell our solution and provide maintenance services, and develop additional new variations.
FINANCIAL FEASIBILITY: we have conducted a sale and revenue forecast in a 5 years´ scenario beyond the project. Our company’s ambition is to reach breakeven in year 2 of commercialization. Five years after entering the market (commercialization expected to start in Q3 2022), we forecast to reach a cumulative profit of more than € 77 M by selling more than 600 containers (including revenues from the maintenance service).